Početna › Limfom › Ohio › Cleveland
Kliničke studije za Limfom u gradu Cleveland, OH
14 studija za Limfom traži sudionike na lokacijama u gradu Cleveland i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.
Službeni tekst studije (engleski)
Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
U tijeku regrutacijaFaza 1/2
- University Hospitals Seidman Cancer Center, Cleveland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
U tijeku regrutacijaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
U tijeku regrutacijaFaza 2
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
U tijeku regrutacijaFaza 2
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
U tijeku regrutacijaFaza 2
- The Cleveland Clinic Foundation, Cleveland
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
U tijeku regrutacijaFaza 3
- Research Site, Cleveland
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
U tijeku regrutacijaFaza 1/2
- Cleveland Clinic, Cleveland
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
U tijeku regrutacijaFaza 1/2
- Cleveland Clinic, Cleveland
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
U tijeku regrutacijaFaza 3
- Cleveland Clinical Taussig Cancer Center, Cleveland
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)
U tijeku regrutacijaFaza 1
- University Hospitals Cleveland Medical Center, Cleveland
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
U tijeku regrutacijaFaza 1
- Cleveland Clinic, Cleveland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
U tijeku regrutacijaFaza 1/2
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
- Cleveland Clinic, Cleveland
Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma
U tijeku regrutacijaFaza 1
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
Studije za Limfom u drugim gradovima
- Houston, TX34 studija
- Boston, MA33 studija
- New York City, NY33 studija
- Washington, DC23 studija
- Baldwin Park, CA21 studija
- Chicago, IL20 studija
- Durham, NC17 studija
- St. Louis, MO15 studija
- Philadelphia, PA15 studija
- Edison, NJ12 studija
- Atlanta, GA12 studija
- Seattle, WA12 studija
Ostale studije u gradu Cleveland
- Nemikrocelularni karcinom pluća43 studija
- Rak (sve vrste)36 studija
- Rak dojke35 studija
- Rak prostate34 studija
- Srčano zatajenje33 studija
- Metastatski karcinom30 studija
- Rak jajnika30 studija
- Rak pluća26 studija
- Kolorektalni rak24 studija
- Kardiovaskularne bolesti22 studija
- Rak endometrija20 studija
- Akutna mijeloična leukemija20 studija
Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.